Literature DB >> 24788321

The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease.

S K Hourigan1, M Oliva-Hemker, S Hutfless.   

Abstract

OBJECTIVES: Adults with inflammatory bowel disease (IBD) have a high prevalence of Clostridium difficile infection (CDI). CDI in children with IBD may differ from adults. We aim to compare the prevalence of CDI in hospitalized pediatric and adult IBD patients and patients without IBD.
METHODS: The rates of CDI per 1,000 IBD and non-IBD hospitalizations between 1993 and 2012 were examined using the Maryland Health Services Cost Review Commission database. Age, sex and calendar year adjusted incidence rate ratios comparing CDI in pediatrics and adults by type of IBD and with patients without IBD were calculated. p values for trend identifying changes in rates over time were calculated.
RESULTS: Among children, the rate of CDI was over 12 times greater in IBD than non-IBD hospitalizations (p < 0.0001) and among adults, the rate of CDI was four times greater in IBD than non-IBD hospitalizations (p < 0.0001). In adults, CDI was significantly higher in ulcerative colitis (UC) than Crohn's disease (60.4 per 1,000 vs. 19.8 per 1,000, p < 0.0001) but in children there was no difference in CDI in UC compared with Crohn's disease (32 per 1,000 vs. 27 per 1,000, p = 0.45). The prevalence of CDI increased in pediatric and adult IBD patients, and patients without IBD, between 1993 and 2012 (p for trend <0.0001).
CONCLUSIONS: CDI was more common in adult patients with UC, and no difference was found between CDI and IBD type in pediatrics. There may be different risk factors for CDI during hospitalization between adults and children with IBD.

Entities:  

Mesh:

Year:  2014        PMID: 24788321     DOI: 10.1007/s10620-014-3169-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Incidence of Clostridium difficile infection in inflammatory bowel disease.

Authors:  Joseph F Rodemann; Erik R Dubberke; Kimberly A Reske; Da Hea Seo; Christian D Stone
Journal:  Clin Gastroenterol Hepatol       Date:  2007-03       Impact factor: 11.382

2.  Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan; Emily L McGinley; Kia Saeian; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2010-09-07       Impact factor: 5.325

Review 3.  Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life.

Authors:  Sushrut Jangi; J Thomas Lamont
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-07       Impact factor: 2.839

4.  Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry.

Authors:  Melvin B Heyman; Barbara S Kirschner; Benjamin D Gold; George Ferry; Robert Baldassano; Stanley A Cohen; Harland S Winter; Patricia Fain; Chris King; Terry Smith; Hashem B El-Serag
Journal:  J Pediatr       Date:  2005-01       Impact factor: 4.406

5.  Risk factors for Clostridium difficile infection.

Authors:  G E Bignardi
Journal:  J Hosp Infect       Date:  1998-09       Impact factor: 3.926

6.  Similar geographic variations of mortality and hospitalization associated with IBD and Clostridium difficile colitis.

Authors:  Amnon Sonnenberg
Journal:  Inflamm Bowel Dis       Date:  2010-03       Impact factor: 5.325

7.  The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.

Authors:  Evelyn M Clayton; Mary C Rea; Fergus Shanahan; Eamonn M M Quigley; Barry Kiely; Colin Hill; R Paul Ross
Journal:  Am J Gastroenterol       Date:  2009-03-24       Impact factor: 10.864

Review 8.  Clostridium difficile infection and inflammatory bowel disease.

Authors:  Sheela S Reddy; Lawrence J Brandt
Journal:  J Clin Gastroenterol       Date:  2013-09       Impact factor: 3.062

9.  Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease.

Authors:  A N Ananthakrishnan; E L McGinley; D G Binion
Journal:  Gut       Date:  2007-09-28       Impact factor: 23.059

10.  Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease.

Authors:  Suchitra K Hourigan; Sankar R Chirumamilla; Tracy Ross; Jonathan E Golub; Shervin Rabizadeh; Shehzad A Saeed; Charles O Elson; Ciaran P Kelly; Karen C Carroll; Maria Oliva-Hemker; Cynthia Sears
Journal:  Inflamm Bowel Dis       Date:  2013-12       Impact factor: 5.325

View more
  24 in total

1.  Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis.

Authors:  Alyce Anderson; Benjamin Click; Claudia Ramos-Rivers; Debbie Cheng; Dmitriy Babichenko; Ioannis E Koutroubakis; Jana G Hashash; Marc Schwartz; Jason Swoger; Arthur M Barrie; Michael A Dunn; Miguel Regueiro; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2017-12       Impact factor: 5.325

Review 2.  The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly.

Authors:  Yao-Wen Cheng; Monika Fischer
Journal:  Curr Treat Options Gastroenterol       Date:  2017-09

3.  Transmission and clearance of potential procarcinogenic bacteria during fecal microbiota transplantation for recurrent Clostridioides difficile.

Authors:  Julia L Drewes; Alina Corona; Uriel Sanchez; Yunfan Fan; Suchitra K Hourigan; Melissa Weidner; Sarah D Sidhu; Patricia J Simner; Hao Wang; Winston Timp; Maria Oliva-Hemker; Cynthia L Sears
Journal:  JCI Insight       Date:  2019-10-03

Review 4.  Fecal microbiota transplantation in children: a brief review.

Authors:  Suchitra K Hourigan; Maria Oliva-Hemker
Journal:  Pediatr Res       Date:  2016-03-16       Impact factor: 3.756

5.  Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Authors:  Zev H Davidovics; Sonia Michail; Maribeth R Nicholson; Larry K Kociolek; Nikhil Pai; Richard Hansen; Tobias Schwerd; Aldo Maspons; Raanan Shamir; Hania Szajewska; Nikhil Thapar; Tim de Meij; Alexis Mosca; Yvan Vandenplas; Stacy A Kahn; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-01       Impact factor: 2.839

Review 6.  Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery.

Authors:  Michael Kriss; Keith Z Hazleton; Nichole M Nusbacher; Casey G Martin; Catherine A Lozupone
Journal:  Curr Opin Microbiol       Date:  2018-07-20       Impact factor: 7.934

7.  Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.

Authors:  Michelle Hughes; Taha Qazi; Adam Berg; Janice Weinberg; Xinhua Chen; Ciaran P Kelly; Francis A Farraye
Journal:  Inflamm Bowel Dis       Date:  2016-04       Impact factor: 5.325

8.  Ulcerative Colitis Patients With Clostridium difficile are at Increased Risk of Death, Colectomy, and Postoperative Complications: A Population-Based Inception Cohort Study.

Authors:  María E Negrón; Ali Rezaie; Herman W Barkema; Kevin Rioux; Jeroen De Buck; Sylvia Checkley; Paul L Beck; Matthew Carroll; Richard N Fedorak; Levinus Dieleman; Remo Panaccione; Subrata Ghosh; Gilaad G Kaplan
Journal:  Am J Gastroenterol       Date:  2016-04-19       Impact factor: 10.864

9.  Proton Pump Inhibitors, H2 Blocker Use, and Risk of Inflammatory Bowel Disease in Children.

Authors:  Naomi R M Schwartz; Susan Hutfless; Lisa J Herrinton; Laura B Amsden; Helene B Fevrier; Matthew Giefer; Dale Lee; David L Suskind; Joseph A C Delaney; Amanda I Phipps
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Nov-Dec

Review 10.  Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections.

Authors:  Lynne Vernice McFarland; Metehan Ozen; Ener Cagri Dinleyici; Shan Goh
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.